ANGO News Alert Angiodynamics (ANGO) 19.01 01/01/2015 14:52:
Post# of 64074
Posted On: 01/01/2015 3:52:36 PM
Angiodynamics (ANGO) 19.01 $ANGO
What's Your Stock's Price Target? - Screen of the Week
Kevin Matras - ZACKS - Tue Dec 30, 12:00AM CST
What's Your Stock's Price Target? - Screen of the Week
LEN: 44.81 (+0.37), FFIV: 130.46 (-2.25), MTOR: 15.15 (-0.24), ANGO: 19.01 (-0.12), RFMD: 16.59 (-0.35)
Shares of ANGO Up 25.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 29, 11:02AM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 3 months, Angiodynamics has returned 25.24% as of today's recent price of $19.08.
ANGO: 19.01 (-0.12)
Uptrend Call Working As Angiodynamics Stock Rises 25.0% (ANGO)
Comtex SmarTrend(R) - Mon Dec 22, 9:44AM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 24.98% as of today's recent price of $19.04.
ANGO: 19.01 (-0.12)
Merit Medical Hits 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 2:20PM CST
Strong third-quarter results, a string of FDA approvals for its new products along with a robust product pipeline, all contribute to the growth trajectory of Merit Medical Systems, Inc. (MMSI).
BSX: 13.25 (-0.12), TFX: 114.82 (-1.40), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 2:37PM CST
Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
BSX: 13.25 (-0.12), BCR: 166.62 (-2.04), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 3:55PM CST
CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues with its sturdy performance in the international markets.
BSX: 13.25 (-0.12), JNJ: 104.57 (-0.79), BCR: 166.62 (-2.04), ANGO: 19.01 (-0.12)
AngioDynamics reports January 8
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 7:37AM CST
ANGO: 19.01 (-0.12)
AngioDynamics to Report Fiscal 2015 Second Quarter Financial Results
GlobeNewswire - Wed Dec 17, 5:30AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 second quarter ended November 30, 2014, on Thursday, January 8, 2015, after the close of the U.S. financial markets.
ANGO: 19.01 (-0.12)
Merit Medical Wins FDA Approval for Multiple Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 5:53PM CST
Developer of medical devices, Merit Medical Systems, Inc. (MMSI), recently announced that the U.S. Food and Drug Administration (FDA) has approved three of its products under section 510(k)
TFX: 114.82 (-1.40), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:50PM CST
AngioDynamics Inc. (ANGO) has entered into a strategic partnership with HealthTrust, covering AngioDynamics' PICC (peripherally inserted central catheter) products.
BCR: 166.62 (-2.04), VASC: 27.16 (-0.19), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
AngioDynamics (ANGO) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Thu Dec 11, 8:47AM CST
Trade-Ideas LLC identified AngioDynamics (ANGO) as a strong and under the radar candidate
ANGO: 19.01 (-0.12)
AngioDynamics Awarded HealthTrust PICC Contract
GlobeNewswire - Tue Dec 09, 5:33AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC (peripherally inserted central catheter) products.
ANGO: 19.01 (-0.12)
Angiodynamics Shares Up 14.5% Since SmarTrend's Buy Recommendation (ANGO)
Comtex SmarTrend(R) - Fri Dec 05, 5:11PM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 14.54% as of today's recent price of $17.45.
ANGO: 19.01 (-0.12)
Hologic (HOLX) Turns Around: Should You Invest Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 1:40PM CST
Hologic's (HOLX) international business, which had been underperforming over the past few quarters, showed a turnaround in the fourth quarter.
ETRM: 1.42 (+0.04), FLDM: 33.73 (+0.17), ANGO: 19.01 (-0.12), HOLX: 26.74 (-0.18)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into AngioDynamics Inc. Regarding Possible Breaches of Fiduciary Duty
Business Wire - Fri Dec 05, 12:57PM CST
Levi & Korsinsky, LLP is investigating AngioDynamics Inc. (NasdaqGS:ANGO) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company.
ANGO: 19.01 (-0.12)
Thoratec Completes Enrollment for HeartMate III CE Mark Trial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:10PM CST
Thoratec Corp (THOR) recently completed enrolment of 50 patients under the HeartMate III CE Mark trial at ten sites across Europe, Canada, and Australia.
FLDM: 33.73 (+0.17), EW: 127.38 (-1.89), THOR: 32.46 (-0.37), ANGO: 19.01 (-0.12)
Varian Medical (VAR) to Display New Technologies at RSNA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 12:50PM CST
Varian Medical Systems (VAR) will showcase new technologies in the ongoing (Nov 30 through Dec 5) annual meet of the Radiological Society of North America (RSNA).
VAR: 86.51 (-1.50), EW: 127.38 (-1.89), ARAY: 7.55 (+0.02), ANGO: 19.01 (-0.12)
Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 1:40PM CST
Cepheid's (CPHD) Xpert Norovirus test comes as the much-desired solution, with its capacity to determine the presence of Norovirus and accurately isolate the different groups of this pathogen
ETRM: 1.42 (+0.04), FLDM: 33.73 (+0.17), CPHD: 54.14 (-0.01), ANGO: 19.01 (-0.12)
What's Your Stock's Price Target? - Screen of the Week
Kevin Matras - ZACKS - Tue Dec 30, 12:00AM CST
What's Your Stock's Price Target? - Screen of the Week
LEN: 44.81 (+0.37), FFIV: 130.46 (-2.25), MTOR: 15.15 (-0.24), ANGO: 19.01 (-0.12), RFMD: 16.59 (-0.35)
Shares of ANGO Up 25.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 29, 11:02AM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 3 months, Angiodynamics has returned 25.24% as of today's recent price of $19.08.
ANGO: 19.01 (-0.12)
Uptrend Call Working As Angiodynamics Stock Rises 25.0% (ANGO)
Comtex SmarTrend(R) - Mon Dec 22, 9:44AM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 24.98% as of today's recent price of $19.04.
ANGO: 19.01 (-0.12)
Merit Medical Hits 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 2:20PM CST
Strong third-quarter results, a string of FDA approvals for its new products along with a robust product pipeline, all contribute to the growth trajectory of Merit Medical Systems, Inc. (MMSI).
BSX: 13.25 (-0.12), TFX: 114.82 (-1.40), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 2:37PM CST
Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
BSX: 13.25 (-0.12), BCR: 166.62 (-2.04), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 3:55PM CST
CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues with its sturdy performance in the international markets.
BSX: 13.25 (-0.12), JNJ: 104.57 (-0.79), BCR: 166.62 (-2.04), ANGO: 19.01 (-0.12)
AngioDynamics reports January 8
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 7:37AM CST
ANGO: 19.01 (-0.12)
AngioDynamics to Report Fiscal 2015 Second Quarter Financial Results
GlobeNewswire - Wed Dec 17, 5:30AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 second quarter ended November 30, 2014, on Thursday, January 8, 2015, after the close of the U.S. financial markets.
ANGO: 19.01 (-0.12)
Merit Medical Wins FDA Approval for Multiple Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 5:53PM CST
Developer of medical devices, Merit Medical Systems, Inc. (MMSI), recently announced that the U.S. Food and Drug Administration (FDA) has approved three of its products under section 510(k)
TFX: 114.82 (-1.40), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:50PM CST
AngioDynamics Inc. (ANGO) has entered into a strategic partnership with HealthTrust, covering AngioDynamics' PICC (peripherally inserted central catheter) products.
BCR: 166.62 (-2.04), VASC: 27.16 (-0.19), ANGO: 19.01 (-0.12), MMSI: 17.33 (-0.20)
AngioDynamics (ANGO) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Thu Dec 11, 8:47AM CST
Trade-Ideas LLC identified AngioDynamics (ANGO) as a strong and under the radar candidate
ANGO: 19.01 (-0.12)
AngioDynamics Awarded HealthTrust PICC Contract
GlobeNewswire - Tue Dec 09, 5:33AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC (peripherally inserted central catheter) products.
ANGO: 19.01 (-0.12)
Angiodynamics Shares Up 14.5% Since SmarTrend's Buy Recommendation (ANGO)
Comtex SmarTrend(R) - Fri Dec 05, 5:11PM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 14.54% as of today's recent price of $17.45.
ANGO: 19.01 (-0.12)
Hologic (HOLX) Turns Around: Should You Invest Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 1:40PM CST
Hologic's (HOLX) international business, which had been underperforming over the past few quarters, showed a turnaround in the fourth quarter.
ETRM: 1.42 (+0.04), FLDM: 33.73 (+0.17), ANGO: 19.01 (-0.12), HOLX: 26.74 (-0.18)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into AngioDynamics Inc. Regarding Possible Breaches of Fiduciary Duty
Business Wire - Fri Dec 05, 12:57PM CST
Levi & Korsinsky, LLP is investigating AngioDynamics Inc. (NasdaqGS:ANGO) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company.
ANGO: 19.01 (-0.12)
Thoratec Completes Enrollment for HeartMate III CE Mark Trial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:10PM CST
Thoratec Corp (THOR) recently completed enrolment of 50 patients under the HeartMate III CE Mark trial at ten sites across Europe, Canada, and Australia.
FLDM: 33.73 (+0.17), EW: 127.38 (-1.89), THOR: 32.46 (-0.37), ANGO: 19.01 (-0.12)
Varian Medical (VAR) to Display New Technologies at RSNA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 12:50PM CST
Varian Medical Systems (VAR) will showcase new technologies in the ongoing (Nov 30 through Dec 5) annual meet of the Radiological Society of North America (RSNA).
VAR: 86.51 (-1.50), EW: 127.38 (-1.89), ARAY: 7.55 (+0.02), ANGO: 19.01 (-0.12)
Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 1:40PM CST
Cepheid's (CPHD) Xpert Norovirus test comes as the much-desired solution, with its capacity to determine the presence of Norovirus and accurately isolate the different groups of this pathogen
ETRM: 1.42 (+0.04), FLDM: 33.73 (+0.17), CPHD: 54.14 (-0.01), ANGO: 19.01 (-0.12)
(0)
(0)Scroll down for more posts ▼